Literature DB >> 6598490

Distribution of citalopram in the blood serum and in the central nervous system of rats after single and multiple dosage.

M Melzacka, A Rurak, A Adamus, W Daniel.   

Abstract

Distribution in rat tissues of citalopram, a potent and specific inhibitor of neuronal 5-HT uptake was uneven. The blood serum level of the drug did not reflect its distribution in the brain tissue and in the spinal cord. Prolonged administration of citalopram enhanced its blood serum, brain and spinal cord AUC values and slowed down its elimination from all investigated tissues. In contrast to imipramine, citalopram penetrated easily to the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6598490

Source DB:  PubMed          Journal:  Pol J Pharmacol Pharm        ISSN: 0301-0244


  5 in total

1.  In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats.

Authors:  F C Kugelberg; G Apelqvist; B Carlsson; J Ahlner; F Bengtsson
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain.

Authors:  Y Chaput; C de Montigny; P Blier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

Review 3.  Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.

Authors:  R J Milne; K L Goa
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

4.  Escitalopram block of hERG potassium channels.

Authors:  Yun Ju Chae; Ji Hyun Jeon; Hong Joon Lee; In-Beom Kim; Jin-Sung Choi; Ki-Wug Sung; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-09-18       Impact factor: 3.000

5.  Neonatal citalopram treatment inhibits the 5-HT depleting effects of MDMA exposure in rats.

Authors:  Tori L Schaefer; Curtis E Grace; Matthew R Skelton; Devon L Graham; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  ACS Chem Neurosci       Date:  2011-10-21       Impact factor: 4.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.